Stocks
IGM Biosciences (IGMS) EBITDA margin US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -20 756% | -11 980% | -7 446% | -21.6% | ||||
| Changes by years, y/y, % | +8 775pp | +4 535pp | -40.1% | ||||||
IGM Biosciences. EBITDA margin, %
IGM Biosciences. EBITDA margin, changes, pp
IGM Biosciences (IGMS) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | FY2025Q2 | LTM ? | |||
| EBITDA margin, % | ? | -3 914% | -12 031% | -8 890% | -6 135% | 68.3% | -21.6% | |
| Changes by years, y/y, % | +10 826pp | +641pp | +778pp | +4 263pp | +3 982pp | |||
| Changes by quarters, q/q, % | +6 484pp | -8 117pp | +3 141pp | +2 755pp | +6 204pp | |||
